drugset / Trial / NCT00191932

Switching to Duloxetine From Other Antidepressants

NCT00191932 ↗

Phase 4 Completed 360 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

A multicentre, randomised, open label study of out-patients with major depression who have failed to respond adequately to antidepressant treatment for their current episode of depression. The study compares outcomes associated with two methods of switching from current antidepressant to duloxetine

Timeline

Start
2004-08
Primary completion
—
Completion
2006-03

Outcome

Met primary endpoint

paper Criteria for noninferiority of the DS group to the STS group, which was the primary objective of the study, were met. PMID 18312043 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule — —